Health Products

Intuniv XR (2017-04-21)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
AF6131D
Recalling Firm
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Intuniv XRTablet (Extended-Release)DIN 024091192 mg Guanfacine (Guanfacine hydrochloride)

Reason

Affected lot may be associated with adverse reaction that may be linked to potential Digoxin contamination.

Depth of distribution

Healthcare professionals across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime